國立成功大學 |
2000-02-15 |
Phosphine-induced oxidative damage in rats: Attenuation by melatonin
|
Hsu, Ching-Hung; Han, Bor-Cheng; Liu, Ming-Yie; Yeh, Ching-Ying; Casida, John E. |
臺北醫學大學 |
2000 |
Phosphine-induced oxidative damage in rats: Attenuation by melatonin.
|
葉錦瑩; Hsu CH; Han BC; Liu MY; Yeh CY; Casida JE. |
臺北醫學大學 |
2000 |
Phosphine-induced oxidative damage in rats: attenuation by melatonin.
|
Hsu CH; Han BC; Liu MY; Yeh CY and Casida JE |
國立成功大學 |
2002-09-30 |
Phosphine-induced oxidative damage in rats: role of glutathione
|
Hsu, Ching-Hung; Chi, Bei-Ching; Liu, Ming-Yie; Li, Jih-Heng; Chen, Chiou-Jong; Chen, Ruey-Yu |
臺北醫學大學 |
2002 |
Phosphine-induced oxidative damage in rats: role of glutathione.
|
陳叡瑜; Hsu CH. Chi BC. Liu MY. Li JH. Chen CJ. Chen RY. |
國立交通大學 |
2014-12-08T15:24:00Z |
Phosphine-Oxide-Containing Bipolar Host Material for Blue Electrophosphorescent Devices
|
Hsu, Fang-Ming; Chien, Chen-Han; Shih, Ping-I; Shu, Ching-Fong |
國立臺灣大學 |
2004 |
Phosphinothricin tolerance in rice (Oryza sativa L.) seedlings is associated with elevated abscisic acid in the leaves
|
Hsu, Yi Ting; Kao, Ching Huei |
高雄醫學大學 |
2005 |
Phospho-JAK1 is aberrantly expressed and is associated with poor prognosis factors in breast cancer
|
葉耀宗;侯明鋒;楊曉芳;蕭國明;蘇鈞煌;袁行修 |
輔英科技大學 |
2005-04-23 |
Phospho-JAK1 is aberrantly expressed and is associated with poor prognostic factors in breast cancer.
|
葉耀宗 |
國立成功大學 |
2013-10-01 |
PhosphoChain: a novel algorithm to predict kinase and phosphatase networks from high-throughput expression data
|
Chen, Wei-Ming; Danziger, Samuel A.; Chiang, Jung-Hsien; Aitchison, John D. |
國家衛生研究院 |
2017-04-06 |
Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages
|
Yang, JX;Hsieh, KC;Chen, YL;Lee, CK;Conti, M;Chuang, TH;Wu, CP;Catherine Jin, SL |
臺大學術典藏 |
2019-07-18T08:41:41Z |
Phosphodiesterase 4B negatively regulates endotoxin-activated interleukin-1 receptor antagonist responses in macrophages
|
Yang, Jing-Xing;Hsieh, Kou-Chou;Chen, Yi-Ling;Chien-Kuo Lee;Conti, Marco;Chuang, Tsung-Hsien;Wu, Chin-Pyng;Jin, S-L Catherine; Yang, Jing-Xing; Hsieh, Kou-Chou; Chen, Yi-Ling; CHIEN-KUO LEE; Conti, Marco; Chuang, Tsung-Hsien; Wu, Chin-Pyng; Jin, S-L Catherine |
臺北醫學大學 |
2009 |
Phosphodiesterase 4D (PDE4D) Gene Variants and Risk of Ischemic Stroke in the Taiwanese Population
|
謝銘松; Hsieh MS; Yu SC; Chung WT; Hsueh YM; Chen FC; Chiu WT and Lee HM |
臺北醫學大學 |
2008 |
Phosphodiesterase 4D (PDE4D) Gene Variants and Risk of Ischemic Stroke in the Taiwanese Population.
|
李宏謨; Hsieh MS; Yu SC; Chung WT; Hsueh YM; Chen FC; Chiu WT; Lee HM |
高雄醫學大學 |
2016 |
Phosphodiesterase 4D gene polymorphisms in sudden sensorineural hearing loss
|
簡禎佑;戴書郁;王凌峰;Hsi, E;張寧家;王遜模;吳明蒼;何坤瑤; Chien, CY;Tai, SY;Wang, LF;Hsi, E;Chang, NC;Wang, HM;Wu, MT;Ho, KY |
嘉南藥理大學 |
2010/03/04 |
Phosphodiesterase 5 Inhibitors with Inducible Nitric Oxide Synthase Suppression and Endothelial Nitric Oxide Synthase-Enhancing Properties Attenuate Hypertensive Cardiomyopathy.
|
J.L. Yeh; C.P. Liu; S.F. Liou; I.J. Chen |
嘉南藥理大學 |
2016-02 |
Phosphodiesterase inhibitor KMUP-3 displays cardioprotection via protein kinase G and increases cardiac output via G-protein-coupled receptor agonist activity and Ca2+ sensitization
|
Liu, Chung-Pin; Yeh, Jwu-Lai; Liou, Shu-Fen; Wu, Bin-Nan; Chen, Ing-Jun |
臺大學術典藏 |
2021-01-29T03:17:13Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Shih-Ping Liu;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; SHIH-PING LIU; Guh J.-H. |
臺大學術典藏 |
2021-06-02T05:43:26Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Hsu L.-C.;Liu S.-P.;Jih-Hwa Guh; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; Hsu L.-C.; Liu S.-P.; JIH-HWA GUH |
臺大學術典藏 |
2021-07-06T07:01:16Z |
Phosphodiesterase type 5 (PDE5) inhibitors sensitize topoisomerase II inhibitors in killing prostate cancer through PDE5-independent impairment of HR and NHEJ DNA repair systems
|
Chang J.-F.;Hsu J.-L.;Sheng Y.-H.;Leu W.-J.;Yu C.-C.;Chan S.-H.;Chan M.-L.;Lih-Ching Hsu;Liu S.-P.;Guh J.-H.; Chang J.-F.; Hsu J.-L.; Sheng Y.-H.; Leu W.-J.; Yu C.-C.; Chan S.-H.; Chan M.-L.; LIH-CHING HSU; Liu S.-P.; Guh J.-H. |
臺大學術典藏 |
2021-01-29T03:17:11Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; SHIH-PING LIU; Guh J.-H. |
臺大學術典藏 |
2021-06-02T05:43:17Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.;Leu W.-J.;Hsu L.-C.;Ho C.-H.;Liu S.-P.;Jih-Hwa Guh; Hsu J.-L.; Leu W.-J.; Hsu L.-C.; Ho C.-H.; Liu S.-P.; JIH-HWA GUH |
臺大學術典藏 |
2021-07-06T07:01:14Z |
Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling
|
Hsu J.-L.; Leu W.-J.; LIH-CHING HSU; Ho C.-H.; Liu S.-P.; Guh J.-H. |
國立臺灣海洋大學 |
2008-12-15 |
Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo
|
Shye-Jye Tang;Ming-Yi Ho;Huan-Chieh Cho;Ying-Chun Lin;Guang-Huan Sun;Kwan-Hwa Chi;Yu-Shan Wang;Ren-Shiang Jhou;Winnie Yang;Kuang-Hui Sun |
國立臺灣海洋大學 |
2008 |
Phosphoglycerate kinase 1-overexpressing lung cancer cells reduce cyclooxygenase 2 expression and promote anti-tumor immunity in vivo.
|
Shye-Jye Tang;Ming-Yi Ho;Huan-Chieh Cho;Ying-Chun Lin;Guang-Huan Sun;Kwan-Hwa Chi;Yu-Shan Wang;Ren-Shiang Jhou;Winnie Yang;Kuang-Hui Sun |